Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

NCT05804331

Conditions: Cancer of Stomach, Digestive System Diseases, Digestive System Neoplasms, +20 more
Locations: Westmead Hospital Sydney, New South Wales, Australia

View Trial Details

Recruiting

Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)

NCT05165407

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Bejing cancer hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial

NCT06855095

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +6 more
Locations: Antoni van Leeuwenhoek Amsterdam, Netherlands

View Trial Details

Recruiting

PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours

NCT05053854

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Recruiting

Clinical Application of the J-PET Scanner Prototype

NCT06242119

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +20 more
Locations: Department of Endocrinology and Nuclear Medicine, University Hospital in Krakow Krakow, Poland

View Trial Details

Recruiting

EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

NCT06785597

Conditions: Mixed Neuroendocrine-Non Neuroendocrine Neoplasm, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: European Institute of Oncology Milan, Italy

View Trial Details

Recruiting

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

NCT02185443

Conditions: Anal Canal Cancer, Anal Canal Carcinoma, Colonic Diseases, +22 more
Locations: Instituto do Cancer do Estado de São Paulo São Paulo, Brazil

View Trial Details

Recruiting

Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients

NCT04917484

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Aarhus University Hospital, department of Nuclear medicine and PET centre Aarhus, Palle Juul-Jensens Boulevard, Denmark

View Trial Details

Recruiting

Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study

NCT05554003

Conditions: Chemotherapy Effect, Frailty, Neoplasms, +7 more
Locations: European Institute of Oncology, IEO, IRCCS Milan, Italy

View Trial Details

Recruiting

Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

NCT06276309

Conditions: Cervical Cancer, Cervical Lesion, China, +20 more
Locations: Fujian Maternity and Child Health Hospital Fuzhou, Fujian, China

Fujian Provincial Hospital Fuzhou, Fujian, China

Ningde Mindong Hospital Ningde, Fujian, China

Putian City first Hospital Putian, Fujian, China

View Trial Details